Two T1D Technology Leaders Partnering to Drive Innovation and Choice
Two leading innovators in the type 1 diabetes (T1D) space have announced a collaborative partnership aimed at enabling those with…
ADA Scientific Sessions Recap—Day #4: Simi Ahmed, Ph.D.
The American Diabetes Association’s Scientific Sessions is almost coming to a close! Here is Simi Ahmed, Ph.D., head of the…
ADA Scientific Sessions Recap—T1D Prevention Research: Jessica Dunne, Ph.D.
There was some really exciting T1D prevention research in day #3, and also screening for type 1 diabetes risk. Here…
A New AP System by Tandem Shows Key Time-in-Range Benefits
A new artificial pancreas system that both doses and takes away insulin is showing critical benefits in helping those with…
ADA Scientific Sessions Recap—Day #3: Dan Finan, Ph.D.
There was some really amazing results out here in San Francisco! Here is Dan Finan, Ph.D., head of the Breakthrough…
First Human Study to Significantly Delay—by Two Years!—Type 1 Diabetes Onset
This is big. No, wait, this is ENORMOUSLY HUGE. Published today in the New England Journal of Medicine, an immune…
ADA Scientific Sessions – The Second Day: Andrew Rakeman, Ph.D.
We’re at the 2019 American Diabetes Association Scientific Sessions, and there’s so much to learn! Here is the recap from…
Sanjoy Dutta, Ph.D.: The Beginning of the ADA Scientific Sessions
The ADA’s Scientific Sessions has begun! Here, in the first recap, is Sanjoy Dutta, Ph.D., who highlights beta cell replacement…
Breakthrough T1D Heads to ADA’s 79th Scientific Sessions
The American Diabetes Association’s (ADA) 79th Scientific Sessions is almost here! From June 7-11, in San Francisco, CA, scientists and…
Breakthrough T1D Urges Congress to Fund Diabetes Research
On June 4, Breakthrough T1D’s President & CEO Aaron J. Kowalski, Ph.D., testified before the U.S. House of Representatives Committee…
